FSS Stock Recent News

Federal Signal (FSS) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.67 per share a year ago.

DOWNERS GROVE, Ill. , July 25, 2024 /PRNewswire/ -- Federal Signal Corporation (NYSE:FSS) (the "Company"), a leader in environmental and safety solutions, today reported results for the second quarter ended June 30, 2024.

DOWNERS GROVE, Ill. , July 23, 2024 /PRNewswire/ -- Federal Signal Corporation (NYSE:FSS) today announced that its Board of Directors declared a quarterly cash dividend of twelve cents ($0.12) per share on its common stock.

DOWNERS GROVE, Ill. , July 18, 2024 /PRNewswire/ -- Federal Signal Corporation (NYSE: FSS) (the "Company"), a leader in environmental and safety solutions, will announce second quarter earnings before the market opens on Thursday, July 25, 2024.

Federal Signal (FSS) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Celebrating the bold leaders who disrupt markets, revolutionize industries and transform lives OAK BROOK, Ill. , June 13, 2024 /PRNewswire/ -- Ernst & Young LLP (EY US) today announced that Jennifer Sherman, President and Chief Executive Officer of Federal Signal Corporation, was named an Entrepreneur Of The Year® 2024 Midwest Award winner.

Federal Signal (FSS) possesses solid growth attributes, which could help it handily outperform the market.

Federal Signal is at its all-time high after outperforming the S&P 500. The stock holds strong technical ratings with steady sales and earnings growth.

-- Approval provides U.S. veterans and other U.S. government agency employees who suffer gait and balance impairment due to multiple sclerosis (MS) access to the only portable neurostimulation therapy with the potential to generate neuroplasticity -- NEWTOWN, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the Company's Portable Neuromodulation Stimulator (PoNS®) device has been approved for inclusion on Lovell Government Services' (“Lovell”) Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage contracts.

OAK BROOK, Ill. , May 16, 2024 /PRNewswire/ -- Federal Signal Corporation (NYSE: FSS) (the "Company"), a leader in environmental and safety solutions, announced today that Jennifer L.